These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 17137775)

  • 21. Transforming growth factor-beta secreted from CD4(+) T cells ameliorates antigen-induced eosinophilic inflammation. A novel high-dose tolerance in the trachea.
    Haneda K; Sano K; Tamura G; Shirota H; Ohkawara Y; Sato T; Habu S; Shirato K
    Am J Respir Cell Mol Biol; 1999 Aug; 21(2):268-74. PubMed ID: 10423411
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Activated human CD4+ T cells induced by dendritic cell stimulation are most sensitive to transforming growth factor-beta: implications for dendritic cell immunization against cancer.
    Lin CM; Wang FH; Lee PK
    Clin Immunol; 2002 Jan; 102(1):96-105. PubMed ID: 11781072
    [TBL] [Abstract][Full Text] [Related]  

  • 23. TGF-β/Smad signaling pathway regulates Th17/Treg balance during Echinococcus multilocularis infection.
    Pang N; Zhang F; Ma X; Zhu Y; Zhao H; Xin Y; Wang S; Chen Z; Wen H; Ding J
    Int Immunopharmacol; 2014 May; 20(1):248-57. PubMed ID: 24631515
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Transforming growth factor-beta in cancer and metastasis.
    Jakowlew SB
    Cancer Metastasis Rev; 2006 Sep; 25(3):435-57. PubMed ID: 16951986
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Human NK cell IFN-gamma production is regulated by endogenous TGF-beta.
    Meadows SK; Eriksson M; Barber A; Sentman CL
    Int Immunopharmacol; 2006 Jun; 6(6):1020-8. PubMed ID: 16644489
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CD4+CD25+ regulatory T cells inhibit natural killer cell functions in a transforming growth factor-beta-dependent manner.
    Ghiringhelli F; Ménard C; Terme M; Flament C; Taieb J; Chaput N; Puig PE; Novault S; Escudier B; Vivier E; Lecesne A; Robert C; Blay JY; Bernard J; Caillat-Zucman S; Freitas A; Tursz T; Wagner-Ballon O; Capron C; Vainchencker W; Martin F; Zitvogel L
    J Exp Med; 2005 Oct; 202(8):1075-85. PubMed ID: 16230475
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Modulation of immunocompetent cells in the synovial fluid TGF-beta].
    Kekow J; Gross WL; Carson DA; Lotz M
    Immun Infekt; 1991 Apr; 19(2):60-1. PubMed ID: 1677345
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Transforming growth factor-beta: an important role in CD4+CD25+ regulatory T cells and immune tolerance.
    Zhang L; Yi H; Xia XP; Zhao Y
    Autoimmunity; 2006 Jun; 39(4):269-76. PubMed ID: 16891215
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neutralization of IL-4 reverses the nonresponsiveness of CD4+ T cells to regulatory T-cell induction in non-responder mouse strains.
    Wang J; Han WG; Foks AC; Huizinga TW; Toes RE
    Mol Immunol; 2010; 48(1-3):137-46. PubMed ID: 20869773
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibition of tumor-specific cytotoxic T-lymphocyte responses by transforming growth factor beta 1.
    Inge TH; Hoover SK; Susskind BM; Barrett SK; Bear HD
    Cancer Res; 1992 Mar; 52(6):1386-92. PubMed ID: 1531782
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Transforming growth factor-beta and all-trans retinoic acid generate ex vivo transgenic regulatory T cells with intestinal homing receptors.
    Moore C; Sauma D; Morales J; Bono MR; Rosemblatt M; Fierro JA
    Transplant Proc; 2009; 41(6):2670-2. PubMed ID: 19715998
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CD28 costimulation overcomes transforming growth factor-beta-mediated repression of proliferation of redirected human CD4+ and CD8+ T cells in an antitumor cell attack.
    Koehler H; Kofler D; Hombach A; Abken H
    Cancer Res; 2007 Mar; 67(5):2265-73. PubMed ID: 17332357
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Acquisition of anergic and suppressive activities in transforming growth factor-beta-costimulated CD4+CD25- T cells.
    Park HB; Paik DJ; Jang E; Hong S; Youn J
    Int Immunol; 2004 Aug; 16(8):1203-13. PubMed ID: 15237111
    [TBL] [Abstract][Full Text] [Related]  

  • 34. TGF-beta: a mobile purveyor of immune privilege.
    Wahl SM; Wen J; Moutsopoulos N
    Immunol Rev; 2006 Oct; 213():213-27. PubMed ID: 16972906
    [TBL] [Abstract][Full Text] [Related]  

  • 35. TGF-beta in the evolution and resolution of inflammatory and immune processes. Introduction.
    Wahl SM
    Microbes Infect; 1999 Dec; 1(15):1247-9. PubMed ID: 10611751
    [No Abstract]   [Full Text] [Related]  

  • 36. Physiological actions and clinical applications of transforming growth factor-beta (TGF-beta).
    Roberts AB; Sporn MB
    Growth Factors; 1993; 8(1):1-9. PubMed ID: 8448037
    [No Abstract]   [Full Text] [Related]  

  • 37. [TGF-β : A key player in age-related loss of skin innate immunity].
    Gutierrez-Mateyron E; Bobé P
    Med Sci (Paris); 2021 Feb; 37(2):189-192. PubMed ID: 33591263
    [TBL] [Abstract][Full Text] [Related]  

  • 38. TGF-beta: a critical modulator of immune cell function.
    Letterio JJ; Roberts AB
    Clin Immunol Immunopathol; 1997 Sep; 84(3):244-50. PubMed ID: 9281382
    [No Abstract]   [Full Text] [Related]  

  • 39. Transforming growth factor beta: the good, the bad, and the ugly.
    Wahl SM
    J Exp Med; 1994 Nov; 180(5):1587-90. PubMed ID: 7964446
    [No Abstract]   [Full Text] [Related]  

  • 40. Potential therapeutic targets for intracerebral hemorrhage-associated inflammation: An update.
    Ren H; Han R; Chen X; Liu X; Wan J; Wang L; Yang X; Wang J
    J Cereb Blood Flow Metab; 2020 Sep; 40(9):1752-1768. PubMed ID: 32423330
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.